AMLX: Amylyx Pharmaceuticals Quarterly Revenue Growth

Amylyx Pharmaceuticals (AMLX) - corporate logo

A complete reboot of the R&D platform following the recall of the primary drug creates a pivot point, as confirmed by the quarterly revenue shift for Amylyx Pharmaceuticals (AMLX). The value 0.00 describes the current status of the metric. Growth is based on the acquisition of new molecules to combat Wolfram syndrome, while stability is provided by lifelong therapy for incurable brain pathologies, guaranteeing long-term sales.

AMLX Amylyx Quarterly Revenue Increase (07/04/2022 - 11/20/2026)

Summary analytical data breakdowns for Amylyx Pharmaceuticals, Inc. (AMLX)

- stock price and consensus target price:
- cash and cash flow indicators:
Initial company analysis:Amylyx Pharmaceuticals Inc (AMLX)
Manufactured products of amylyx.com

The scale of Amylyx Pharmaceuticals (AMLX) operations within the neurodegenerative pathology segment drives revenue dynamics, where the current quarterly revenue growth rate stands at 0.00. This metric measures the pace of sales expansion relative to the previous quarter, confirming the effectiveness of the closed treatment loop and the high switching costs for patients moving to alternative protocols, which ensures the stability of the business's fundamental valuation.

Main competitors

BIIB - Revenue Growth QoQ|NBIX (Neurocrine Biosciences) - Sales Growth QoQ|RGC: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Axsome (AXSM)|Revenue Growth QoQ ACADIA Pharmaceuticals Inc|Quarterly Sales Growth Xenon Pharmaceuticals Inc (XENE)|Quarterly Revenue Growth VKTX|Quarterly Revenue Growth supernus.com (SUPN)|Revenue Growth QoQ Catalyst Pharmaceuticals, Inc. CPRX|DNLI (Denali Therapeutics Inc.) - Revenue Dynamics QoQ|Harmony Corp - Quarterly Revenue Growth|BHVN: Revenue Growth QoQ|TRVI (Trevi Pharma) - Quarterly Sales Growth|Quarterly Revenue Growth Rate praxismedicines.com (PRAX)|AVXL (Anavex Life Sciences Corp) - Quarterly Revenue Growth|Revenue Growth QoQ CBLL|Quarterly Sales Growth PRTA (prothena.com)|Alector - Sales Growth QoQ|Quarterly Revenue Growth ANNX (Annexon Biosciences)|OMER: Sales Growth QoQ|NGNE - Revenue Growth QoQ|ACIU - Quarterly Revenue Growth|Voyager Corp (VYGR) - Revenue Growth QoQ|NMRA - Quarterly Sales Growth Rate|Revenue Growth QoQ Scilex|TVGN (Tevogen Bio) - Sales Change QoQ|Quarterly Sales Growth ACOG (alphacognition.com)|Quarterly Sales Growth Rate Cognition Therapeutics, Inc.|Quarterly Revenue Growth IKT (Inhibikase Pharma)|Quarterly Revenue Growth Cassava Sciences, Inc. SAVA|ASRT - Revenue Growth QoQ|Quarterly Revenue Growth Rate Coya Therapeutics Inc|Vistagen Therapeutics (VTGN) - Revenue Growth QoQ|OVID - Quarterly Sales Growth Rate|Revenue Growth QoQ Acumen Pharmaceuticals, Inc|Revenue Growth QoQ CRVO|Quarterly Revenue Growth ATHE|Clene - Sales Growth QoQ|Quarterly Revenue Growth PEPG (pepgen.com)|JUNS: Sales Growth QoQ|RLMD - Revenue Growth QoQ|Quarterly Revenue Growth Rate Annovis Bio, Inc.|GRCE (Grace Therapeutics) - Quarterly Sales Growth|Quarterly Revenue Growth Rate Firefly Neuroscience (AIFF)|Quarterly Sales Growth KLTO|NRSN: Quarterly Revenue Increase|Revenue Growth QoQ Reviva Pharmaceuticals Holdings (RVPH)|Quarterly Sales Growth MetaVia, Inc. MTVA|Revenue Growth QoQ NeurAxis NRXS|HSDT: Sales Growth QoQ|passagebio.com - Quarterly Revenue Growth|NEUP - Quarterly Revenue Growth|Minerva Neurosciences Corp (NERV) - Revenue Growth QoQ|Revenue Dynamics QoQ ATHA (Athira)|ADXN (Addex Therapeutics Ltd.) - Quarterly Revenue Growth|Sales Growth QoQ ALZN (Alzamend Neuro)|Revenue Growth QoQ Cyclerion Therapeutics Inc. (CYCN)|Quarterly Revenue Growth Protagenic Therapeutics, Inc. (PTIX)|Quarterly Revenue Growth KTTA (Pasithea Therapeutics Corp)|CRGT - Quarterly Sales Growth|ATXI - Revenue Growth QoQ|BCLI: Revenue Growth QoQ|Cara Therapeutics (CARA) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Chromocell Therapeutics Corp (CHRO)|Quarterly Sales Growth ELYM|Quarterly Revenue Growth Rate intracellulartherapies.com ITCI|Revenue Growth QoQ Longboard Pharmaceuticals (LBPH)|MRNS (Marinus Pharmaceuticals) - Quarterly Revenue Increase|Revenue Growth QoQ NKGen NKGN|Quarterly Revenue Growth NeuroBo Pharmaceuticals Inc NRBO|SAGE: Quarterly Sales Growth|Quarterly Sales Growth Rate Synaptogenix, Inc SNPX|TRVN: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Vigil Neuroscience (VIGL)|Revenue Growth QoQ Anew Medical, Inc.|CERE (Cerevel Therapeutics, Inc.) - Sales Change QoQ